121 related articles for article (PubMed ID: 2108911)
1. Prevention of infection in acute leukemia.
Maschmeyer G; Daenen S; de Pauw BE; de Vries-Hospers HG; Dekker AW; Donnelly JP; Gaus W; Haralambie E; Kern W; Konrad H
Haematol Blood Transfus; 1990; 33():525-30. PubMed ID: 2108911
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
3. Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.
Arning M; Wolf HH; Aul C; Heyll A; Scharf RE; Scheider W
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():137-42. PubMed ID: 2286588
[TBL] [Abstract][Full Text] [Related]
4. Prevention of infection in the neutropenic patient.
Verhoef J; Rozenberg-Arska M; Dekker A
Rev Infect Dis; 1989; 11 Suppl 7():S1545-50. PubMed ID: 2513630
[TBL] [Abstract][Full Text] [Related]
5. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
Dekker AW; Rozenberg-Arska M; Verhoef J
Ann Intern Med; 1987 Jan; 106(1):7-11. PubMed ID: 3466563
[TBL] [Abstract][Full Text] [Related]
6. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
[TBL] [Abstract][Full Text] [Related]
7. Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
Verhoef J; Rozenberg-Arska M; Dekker A
Haematol Blood Transfus; 1987; 30():188-93. PubMed ID: 3114058
[No Abstract] [Full Text] [Related]
8. Ciprofloxacin for infection prevention in patients with acute leukemia.
Rozenberg-Arska M; Dekker AW
Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S45-7. PubMed ID: 3325929
[TBL] [Abstract][Full Text] [Related]
9. Prevention of infection in children with acute leukaemia. No major difference between total and selective bowel decontamination.
Muis N; Kamps WA; Dankert J
Support Care Cancer; 1996 May; 4(3):200-6. PubMed ID: 8739653
[TBL] [Abstract][Full Text] [Related]
10. Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
Bow EJ; Rayner E; Louie TJ
Am J Med; 1988 May; 84(5):847-54. PubMed ID: 3284340
[TBL] [Abstract][Full Text] [Related]
11. Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group.
Donnelly JP; Maschmeyer G; Daenen S
Eur J Cancer; 1992; 28A(4-5):873-8. PubMed ID: 1524913
[TBL] [Abstract][Full Text] [Related]
12. Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.
Rozenberg-Arska M; Dekker AW; Verhoef J
Infection; 1983; 11(3):167-9. PubMed ID: 6604030
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.
Maschmeyer G; Haralambie E; Gaus W; Kern W; Dekker AW; De Vries-Hospers HG; Sizoo W; König W; Gutzler F; Daenen S
Infection; 1988; 16(2):98-104. PubMed ID: 3286509
[TBL] [Abstract][Full Text] [Related]
15. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
16. Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.
Prentice HG; Hann IM; Nazareth B; Paterson P; Bhamra A; Kibbler CC
Br J Haematol; 2001 Oct; 115(1):46-52. PubMed ID: 11722408
[TBL] [Abstract][Full Text] [Related]
17. A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
Kelsey SM; Collins PW; Delord C; Weinhard B; Newland AC
Br J Haematol; 1990 Dec; 76 Suppl 2():10-3. PubMed ID: 2149044
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin for infection prophylaxis in granulocytopenic patients with acute leukemia.
Cortellaro M; Cofrancesco E; Pasargiklian I; Bianchi R; Pozzoli E; Annaloro C; Ranzi ML; Mascheroni E; Polli N
Haematologica; 1990; 75(6):541-5. PubMed ID: 2098296
[TBL] [Abstract][Full Text] [Related]
19. Norfloxacin versus cotrimoxazole for infection prophylaxis in granulocytopenic patients with acute leukemia. A prospective randomized study.
Orlandi E; Navarra A; Cruciani M; Caldera D; Morra E; Castagnola C; Concia E; Bernasconi C
Haematologica; 1990; 75(3):296-8. PubMed ID: 2227631
[TBL] [Abstract][Full Text] [Related]
20. Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis.
Kurrle E; Dekker AW; Gaus W; Haralambie E; Krieger D; Rozenberg-Arska M; de Vries-Hospers HG; van der Waaij D; Wendt F
Infection; 1986; 14(5):226-32. PubMed ID: 3491791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
